FDA’s Office of Prescription Drug Promotion (OPDP) sent its third Untitled Letter of 2019 to Aclaris Therapeutics, Inc., June 14 over a direct-to-consumer video. The video was an interview featuring a paid Aclaris spokesperson regarding Eskata (hydrogen peroxide) topical solution that was originally broadcast on ABC’s “The View” on Sept. 19, 2018, and can be accessed through ... Read More